Detecting cognitive impairment in primary care: Performance assessment of three screening instruments

Journal of Alzheimer's Disease

Volumn 11, Issue 3, 2007, Pages 323-335

  Trenkle, Douglas L ^a   Shankle, William R ^b,c   Azen, Stanley P ^d  

^a Maine Coast Memorial Hospital   (United States)

^b Medical Care Corporation   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Accuracy; Alzheimer's disease; Early detection; Mild cognitive impairment; Normal aging; Prevalence; Primary care; Receiver operating characteristic; Sensitivity; Validity

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DECISION MAKING; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE SEVERITY; EARLY DIAGNOSIS; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; KAPPA STATISTICS; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL PERFORMANCE; MINI MENTAL STATE EXAMINATION; PREDICTIVE VALIDITY; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SCREENING TEST; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VALIDITY;

EID: 34247120871     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2007-11309     Document Type: Article

References (74)

1. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Washington, DC, 2000.
2. J.W. Ashford, S. Borson, R. O'Hara, P. Dash, L. Frank, P. Robert, W.R. Shankle, M.C. Tierney, H. Brodaty, F.A. Schmitt, H.C. Kraemer and H. Buschke, Should older adults be screened for dementia? Alzheimer's & Dementia 2 (2006), 76-85.
3. S.R. Auer, S.G. Sclan, R.A. Yaffee and B. Reisberg, The neglected half of Alzheimer disease: cognitive and functional concomitants of severe dementia, J Am Geriatr Soc 42 (1994), 1266-1272.
4. L. Backman, B.J. Small and L. Fratiglioni, Stability of the preclinical episodic memory deficit in Alzheimer's disease, Brain 124 (2001), 96-102.
5. U. Beinhoff, V. Hilbert, D. Bittner, G. Gron and M.W. Riepe, Screening for cognitive impairment: a triage for outpatient care, Dement Geriatr Cogn Disord 20 (2005), 278-285.
6. H.G. Belanger, K. Wilder-Willis, P. Malloy, S. Salloway, R.F. Hamman and J. Grigsby, Assessing motor and cognitive regulation in AD, MCI, and controls using the Behavioral Dyscontrol Scale, Arch Clin Neuropsychol 20 (2005), 183-189.
7. D.A. Bennett, J.A. Schneider, Z. Arvanitakis, J.F. Kelly, N.T. Aggarwal, R.C. Shah and R.S. Wilson, Neuropathology of older persons without cognitive impairment from two community-based studies, Neurology 66 (2006), 1837-1844.
8. A.D. Benson, M.J. Slavin, T.T. Tran, J.R. Petrella and P.M. Doraiswamy, Screening for Early Alzheimer's Disease: Is There Still a Role for the Mini-Mental State Examination? Prim Care Companion J Clin Psychiatry 7 (2005), 62-69.
9. C.M. Callahan, H.C. Hendrie and W.M. Tierney, Documentation and evaluation of cognitive impairment in elderly primary care patients, Ann Intern Med 122 (1995), 422-429.
10. P. Chen, G. Ratcliff, S.H. Belle, J.A. Cauley, S.T. DeKosky and M. Ganguli, Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study, Arch Gen Psychiatry 58 (2001), 853-858.
11. M.M. Cherrier, A.M. Matsumoto, J.K. Amory, S. Asthana, W. Bremner, E.R. Peskind, M.A. Raskind and S. Craft, Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment, Neurology 64 (2005), 2063-2068.
12. H.C. Chui, J.I. Victoroff, D. Margolin, W. Jagust, R. Shankle and R. Katzman, Criteria for the Diagnosis of Ischemic Vascular Dementia Proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers, Neurology 42 (1992), 473-480.
13. A. Collie and P. Maruff, The neuropsychology of preclinical Alzheimer's disease and mild cognitive impairment, Neurosci Biobehav Rev 24 (2000), 365-374.
14. A. Cunje, D.W. Molloy, T.I. Standish and D.L. Lewis, Alternate forms of logical memory and verbal fluency tasks for repeated testing in early cognitive changes, Int Psychogeriatr 19 (2006), 65-75.
15. G.M. Doniger, D.M. Zucker, A. Schweiger, T. Dwolatzky, H. Chertkow, H. Crystal and E.S. Simon, Towards practical cognitive assessment for detection of early dementia: a 30-minute computerized battery discriminates as well as longer testing, Curr Alzheimer Res 2 (2005), 117-124.
16. T. Dwolatzky, V. Whitehead, G.M. Doniger, E.S. Simon, A. Schweiger, D. Jaffe and H. Chertkow, Validity of the Mindstreams computerized cognitive battery for mild cognitive impairment, J Mol Neurosci 24 (2004), 33-44.
17. M.F. Elias, A. Beiser, P.A. Wolf, R. Au, R.F. White and R.B. D'Agostino, The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort, Arch Neurol 57 (2000), 808-813.
18. C. Esteban-Santillan, R. Praditsuwan, H. Ueda and D.S. Geldmacher, Clock drawing test in very mild Alzheimer's disease, J Am Geriatr Soc 46 (1998), 1266-1269.
19. M.R. Farlow and M.L. Lilly, Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years, BMC Geriatr 5 (2005), 3.
20. H. Feldman, A.R. Levy, G.Y. Hsiung, K.R. Peters, A. Donald, S.E. Black, R.W. Bouchard, S.G. Gauthier, D.A. Guzman, D.B. Hogan, A. Kertesz and K. Rockwood, ACCORD Study Group, A Canadian Cohort Study of Cognitive Impairment and Related Dementias (ACCORD): Study Methods and Baseline Results, Neuroepidemiology 22 (2003), 265-274.
21. M.F. Folstein, S.E. Folstein and P.R. McHugh, "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res 12 (1975), 189-198.
22. J.E. Galvin, C.M. Roe, C. Xiong and J.C. Morris, Validity and reliability of the AD8 informant interview in dementia, Neurology 67 (2006), 1942-1948.
23. M. Ganguli, E. Rodriguez, B. Mulsant, S. Richards, R. Pandav, J.V. Bilt, H.H. Dodge, G.P. Stoehr, J. Saxton, R.K. Morycz, R.T. Rubin, B. Farkas and S.T. DeKosky, Detection and management of cognitive impairment in primary care: The Steel Valley Seniors Survey, J Am Geriatr Soc 52 (2004), 1668-1675.
24. R. Goekoop, P. Scheltens, F. Barkhof and S.A. Rombouts, Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation - a pharmacological fMRI study, Brain 129 (2006), 141-157.
25. M.C. Greenaway, L.H. Lacritz, D. Binegar, M.F. Weiner, A. Lipton and C. Munro Cullum, Patterns of verbal memory performance in mild cognitive impairment, Alzheimer disease, and normal aging, Cogn Behav Neurol 19 (2006), 79-84.
26. C.T. Gualtieri and L.G. Johnson, Neurocognitive testing supports a broader concept of mild cognitive impairment, Am J Alzheimers Dis Other Demen 20 (2005), 359-366.
27. T. Hanninen, M. Hallikainen, S. Tuomainen, M. Vanhanen and H. Soininen, Prevalence of mild cognitive impairment: a population-based study in elderly subjects, Acta Neurol Scand 106 (2002), 148-154.
28. L.E. Hebert, P.A. Scherr, J.L. Bienias, D.A. Bennett and D.A. Evans, Alzheimer disease in the US population: prevalence estimates using the 2000 census, Arch Neurol 60 (2003), 1119-1122.
29. C. Holmes, N. Cairns, P. Lantos and A. Mann, Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies, Br J Psychiatry 174 (1999), 45-50.
30. G.A. Hopp, R.A. Dixon, M. Grut and L. Backman, Longitudinal and psychometric profiles of two cognitive status tests in very old adults, J Clin Psychol 53 (1997), 673-686.
31. D.B. Howieson, A. Dame, R. Camicioli, G. Sexton, H. Payami and J.A. Kaye, Cognitive markers preceding Alzheimer's dementia in the healthy oldest old, J Am Geriatr Soc 45 (1997), 584-589.
32. G.Y. Hsiung, A.D. Sadovnick and H. Feldman, Apolipoprotein E4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging, CMAJ 171 (2004), 863-867.
33. C.A. De Jager, E. Hogervorst, M. Combrinck and M.M. Budge, Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease, Psychol Med 33 (2003), 1039-1050.
34. J. Koontz and A. Baskys, Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: a double-blind placebo-controlled study, Am J Alzheimers Dis Other Demen 20 (2005), 295-302.
35. M. Li, T.P. Ng, E.H. Kua and S.M. Ko, Brief informant screening test for mild cognitive impairment and early Alzheimer's disease, Dement Geriatr Cogn Disord 21 (2006), 392-402.
36. W.R. Markesbery, F.A. Schmitt, R.J. Kryscio, D.G. Davis, C.D. Smith and D.R. Wekstein, Neuropathologic substrate of mild cognitive impairment, Arch Neurol 63 (2006), 38-46. 14
37. A.C. McKee, R. Au, H.J. Cabral, N.W. Kowall, S. Seshadri, C.A. Kubilus, J. Drake and P.A. Wolf, Visual association pathology in preclinical Alzheimer disease, J Neuropathol Exp Neurol 65 (2006), 621-630.
38. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price and E.M. Stadlan, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology 34 (1984), 939-944.
39. M.S. Mittelman, S.H. Ferris, E. Shulman, G. Steinberg and B. Levin, A family intervention to delay nursing home placement of patients with Alzheimer disease. A randomized controlled trial, JAMA 276 (1996), 1725-1731.
40. L. Mosconi, W.H. Tsui, S. De Santi, J. Li, H. Rusinek, A. Convit, Y. Li, M. Boppana and M.J. de Leon, Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis, Neurology 64 (2005), 1860-1867.
41. M.J. Muller, D. Greverus, C. Weibrich, P.R. Dellani, A. Scheurich, P. Stoeter and A. Fellgiebel, Diagnostic utility of hippocampal size and mean diffusivity in amnestic MCI, Neurobiol Aging (2006) [online publication ahead of press].
42. Z.S. Nasreddine, N.A. Phillips, V. Bedirian, S. Charbonneau, V. Whitehead, I. Collin, J.L. Cummings and H. Chertkow, The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment, J Am Geriatr Soc 53 (2005), 695-699.
43. C. Pennanen, M. Kivipelto, S. Tuomainen, P. Hartikainen, T. Hanninen, M.P. Laakso, M. Hallikainen, M. Vanhanen, A. Nissinen, E.L. Helkala, P. Vainio, R. Vanninen, K. Partanen and H. Soininen, Hippocampus and entorhinal cortex in mild cognitive impairment and early AD, Neurobiol Aging 25 (2004), 303-310.
44. R. Perneczky, C. Pohl, C. Sorg, J. Hartmann, K. Komossa, P. Alexopoulos, S. Wagenpfeil and A. Kurz, Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues, Age Ageing 35 (2006), 240-245.
45. R.C. Petersen, G.E. Smith, S.C. Waring, R.J. Ivnik, E.G. Tangalos and E. Kokmen, Mild cognitive impairment: clinical characterization and outcome, Arch Neurol 56 (1999), 303-308.
46. R.C. Petersen, R. Doody, A. Kurz, R.C. Mohs, J.C. Morris, P.V. Rabins, K. Ritchie, M. Rossor, L. Thal and B. Winblad, Current concepts in mild cognitive impairment, Arch Neurol 58 (2001), 1985-1992.
47. R.C. Petersen, J.C. Stevens, M. Ganguli, E.G. Tangalos, J.L. Cummings and S.T. DeKosky, Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology 56 (2001), 1133-1142.
48. R.C. Petersen and J. O'Brien, Mild cognitive impairment should be considered for DSM-V, J Geriatr Psychiatry Neurol 19 (2006), 147-154.
49. R.C. Petersen, J.E. Parisi, D.W. Dickson, K.A. Johnson, D.S. Knopman, B.F. Boeve, G.A. Jicha, R.J. Ivnik, G.E. Smith, E.G. Tangalos, H. Braak and E. Kokmen, Neuropathologic features of amnestic mild cognitive impairment, Arch Neurol 63 (2006), 665-672.
50. J.L. Purser, G.G. Fillenbaum and R.B. Wallace, Memory complaint is not necessary for diagnosis of mild cognitive impairment and does not predict 10-year trajectories of functional disability, word recall, or short portable mental status questionnaire limitations, J Am Geriatr Soc 54 (2006), 335-338.
51. B. Reisberg, S.H. Ferris, E.H. Franssen, E. Shulman, I. Monteiro, S.G. Sclan, G. Steinberg, A. Kluger, C. Torossian, M.J. de Leon and E. Laska, Mortality and temporal course of probable Alzheimer's disease: a 5-year prospective study, Int Psychogeriatr 8 (1996), 291-311.
52. B. Reisberg, S. Ferris, M.J. de Leon, C. Torossian, S. Kadiyala and W. Zhu, Subjective Cognitive Impairment: The pre-Mild Cognitive Impairment stage of brain degeneration: Longitudinal outcome after a mean of 7 years follow-up, Neuropsychopharmacology 30 (2005), S81.
53. E.H. Rubin, M. Storandt, J.P. Miller, D.A. Kinscherf, E.A. Grant, J.C. Morris and L. Berg, A prospective study of cog nitive function and onset of dementia in cognitively healthy elders, Arch Neurol 55 (1998), 395-401.
54. E. Saka, E. Mihci, M.A. Topcuoglu and S. Balkan, Enhanced cued recall has a high utility as a screening test in the diagnosis of Alzheimer's disease and mild cognitive impairment in Turkish people, Arch Clin Neuropsychol 21 (2006), 745-751.
55. S. Salloway, S. Ferris, A. Kluger, R. Goldman, T. Griesing, D. Kumar and S. Richardson, Donepezil 401 Study Group, Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial, Neurology 63 (2004), 651-657.
56. M. Sano, C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, M. Grundman, P. Woodbury, J. Growdon, C.W. Cotman, E. Pfeiffer, L.S. Schneider and L.J. Thal, A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study, New Eng J Med 336 (1997), 1216-1222.
57. A.M. Schrijnemaekers, C.A. de Jager, E. Hogervorst and M.M. Budge, Cases with mild cognitive impairment and Alzheimer's disease fail to benefit from repeated exposure to episodic memory tests as compared with controls, J Clin Exp Neuropsychol 28 (2006), 438-455.
58. S.G. Sclan and B. Reisberg, Functional assessment staging (FAST) in Alzheimer's disease: reliability, validity, and ordinality, Int Psychogeriatr 4 (1992), 55-69.
59. B. Seltzer, P. Zolnouni, M. Nunez, R. Goldman, D. Kumar, J. Ieni and S. Richardson, Donepezil 402 Study Group, Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial, Arch Neurol 61 (2004), 1852-1856.
60. W.R. Shankle, S. Mani, M.J. Pazzani and P. Smyth, Dementia Screening with Machine Learning methods, in: Intelligent Data Analysis in Medicine and Pharmacology, E. Keravnou, N. Lavrac and B. Zupan, eds, Kluwer Academic Publishers, 1997, pp. 149-165.
61. W.R. Shankle, A.K. Romney, J. Hara, D. Fortier, M.B. Dick, J.M. Chen, T. Chan and X. Sun, Methods to improve the detection of mild cognitive impairment, Proc Natl Acad Sci USA 102 (2005), 4919-4924.
62. B.J. Small, L. Fratiglioni, M. Viitanen, B. Winblad and L. Backman, The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample, Arch Neurol 57 (2000), 839-844.
63. M.R. Somerfield, C.S. Weisman, W. Ury, G.A. Chase and M.F. Folstein, Physician practices in the diagnosis of dementing disorders, J Am Geriatr Soc 39 (1991), 172-175.
64. T.I. Standish, D.W. Molloy, A. Cunje and D.L. Lewis, Do the ABCS 135 short cognitive screen and its subtests discriminate between normal cognition, mild cognitive impairment and dementia? Int J Geriatr Psychiatry (2006) [online publication ahead of press].
65. J.E. Storey, J.T. Rowland, D. Basic and D.A. Conforti, A comparison of five clock scoring methods using ROC (receiver operating characteristic) curve analysis, Int J Geriatr Psychiatry 16 (2001), 394-399.
66. J.E. Storey, J.T. Rowland, D. Basic and D.A. Conforti, Accuracy of the clock drawing test for detecting dementia in a multicultural sample of elderly Australian patients, Int Psychogeriatr 14 (2002), 259-271.
67. M.C. Tierney, J.P. Szalai, W.G. Snow, R.H. Fisher, A. Nores, G. Nadon, E. Dunn and P.H. St George-Hyslop, Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study, Neurology 46 (1996), 661-665.
68. J. Touchon and K. Ritchie, Prodromal cognitive disorder in Alzheimer's disease, Int J Geriatr Psychiatry 14 (1999), 556-563.
69. V.G. Valcour, K.H. Masaki, J.D. Curb and P.L. Blanchette, The detection of dementia in the primary care setting, Arch Intern Med 160 (2000), 2964-2968.
70. G.S. Watson, B.A. Cholerton, M.A. Reger, L.D. Baker, S.R. Plymate, S. Asthana, M.A. Fishel, J.J. Kulstad, P.S. Green, D.G. Cook, S.E. Kahn, M.L. Keeling and S. Craft, Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study, Am J Geriatr Psychiatry 13 (2005), 950-958.
71. Y.I. Watson, C.L. Arfken and S.J. Birge, Clock completion: an objective screening test for dementia, J Am Geriatr Soc 41 (1993), 1235-1240.
72. K. Welsh, N. Butters, J. Hughes, R. Mohs and A. Heyman, Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures, Arch Neurol 48 (1991), 278-281.
73. K.A. Welsh, N. Butters, R.C. Mohs, D. Beekly, S. Edland, G. Fillenbaum and A. Heyman, The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery, Neurology 44 (1994), 609-614.
74. K. Yaffe, K. Krueger, S.R. Cummings, T. Blackwell, V.W. Henderson, S. Sarkar, K. Ensrud and D. Grady, Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial, Am J Psychiatry 162 (2005), 683-690.